(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 7.13% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Lantheus Holdings's revenue in 2025 is $1,536,699,000.On average, 7 Wall Street analysts forecast LNTH's revenue for 2025 to be $108,920,922,075, with the lowest LNTH revenue forecast at $107,256,034,117, and the highest LNTH revenue forecast at $112,392,390,582. On average, 6 Wall Street analysts forecast LNTH's revenue for 2026 to be $118,176,395,657, with the lowest LNTH revenue forecast at $109,816,601,908, and the highest LNTH revenue forecast at $123,561,751,946.
In 2027, LNTH is forecast to generate $131,384,594,422 in revenue, with the lowest revenue forecast at $119,850,623,703 and the highest revenue forecast at $141,069,919,604.